These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2991221)

  • 41. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
    Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural requirements of the epidermal growth factor receptor for tyrosine phosphorylation of eps8 and eps15, substrates lacking Src SH2 homology domains.
    Alvarez CV; Shon KJ; Miloso M; Beguinot L
    J Biol Chem; 1995 Jul; 270(27):16271-6. PubMed ID: 7608194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture.
    Fujioka T; Ui M
    Eur J Biochem; 2001 Jan; 268(1):25-34. PubMed ID: 11121098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and characterization of human erythrocyte phosphatidylinositol 4-kinase. Phosphatidylinositol 4-kinase and phosphatidylinositol 3-monophosphate 4-kinase are distinct enzymes.
    Graziani A; Ling LE; Endemann G; Carpenter CL; Cantley LC
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):39-45. PubMed ID: 1318025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidermal growth factor stimulates a protein tyrosine kinase which is separable from the epidermal growth factor receptor.
    Filhol O; Chambaz EM; Gill GN; Cochet C
    J Biol Chem; 1993 Dec; 268(36):26978-82. PubMed ID: 8262933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation.
    Weber W; Bertics PJ; Gill GN
    J Biol Chem; 1984 Dec; 259(23):14631-6. PubMed ID: 6094567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal-growth-factor-dependent activation of the src-family kinases.
    Osherov N; Levitzki A
    Eur J Biochem; 1994 Nov; 225(3):1047-53. PubMed ID: 7525285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular size of the epidermal growth factor receptor-kinase as determined by radiation inactivation.
    Haigler HT; End D; Kempner E
    J Biol Chem; 1985 Feb; 260(4):2178-84. PubMed ID: 2982812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor.
    Bertics PJ; Gill GN
    J Biol Chem; 1985 Nov; 260(27):14642-7. PubMed ID: 2997217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification and characterization of a pp60c-src-related tyrosine kinase that effectively phosphorylates a synthetic peptide derived from p34cdc2.
    Litwin CM; Cheng HC; Wang JH
    J Biol Chem; 1991 Feb; 266(4):2557-66. PubMed ID: 1703531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro.
    Giorgetti S; Ballotti R; Kowalski-Chauvel A; Tartare S; Van Obberghen E
    J Biol Chem; 1993 Apr; 268(10):7358-64. PubMed ID: 8385105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amiloride directly inhibits growth factor receptor tyrosine kinase activity.
    Davis RJ; Czech MP
    J Biol Chem; 1985 Feb; 260(4):2543-51. PubMed ID: 2982824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholesterol and phosphoinositides increase affinity of the epidermal growth factor receptor.
    den Hartigh JC; van Bergen en Henegouwen PM; Boonstra J; Verkleij AJ
    Biochim Biophys Acta; 1993 Jun; 1148(2):249-56. PubMed ID: 8389198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between type II phosphatidylinositol 4-kinase activity and protein tyrosine phosphorylation in membranes from normal and sickle red cells.
    De Neef RS; Hardy-Dessources MD; Giraud F
    Eur J Biochem; 1996 Feb; 235(3):549-56. PubMed ID: 8654400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 42,000-molecular weight EGF receptor has protein kinase activity.
    Basu M; Biswas R; Das M
    Nature; 1984 Oct 4-10; 311(5985):477-80. PubMed ID: 6090943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase.
    Countaway JL; Nairn AC; Davis RJ
    J Biol Chem; 1992 Jan; 267(2):1129-40. PubMed ID: 1309762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.
    Whitman M; Kaplan D; Roberts T; Cantley L
    Biochem J; 1987 Oct; 247(1):165-74. PubMed ID: 2825654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.
    Cohen S; Carpenter G; King L
    J Biol Chem; 1980 May; 255(10):4834-42. PubMed ID: 6246084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of protein kinase C activation after epidermal growth factor binding on epidermal growth factor receptor phosphorylation.
    King CS; Cooper JA
    J Biol Chem; 1986 Aug; 261(22):10073-8. PubMed ID: 3015918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.